• Info
  • Insider Ownership

Insider Trading & Ownership of Michael A. Panzara

Location
Cambridge, MA
Signature
/s/ Mark Worthington, Attorney in fact for Michael A. Panzara
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Michael A. Panzara and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Michael A. Panzara has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value is not available.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Athira Pharma, Inc. ().
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Michael A. Panzara

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
LONA Athira Pharma, Inc. Director 30 May 2025
WVE Wave Life Sciences Ltd. Chief Medical Officer, Head of Therapeutics Discovery and Development 25 Jul 2022

Insider Transactions Reported by Michael A. Panzara:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored